Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer
Clinical trial NCT05595590 · RECRUITING
Trial details
- NCT number
- NCT05595590
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-20
- Primary completion
- 2024-10-19
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.